Specific inhibition of p110α subunit of PI3K: putative therapeutic strategy for KRAS mutant colorectal cancers

Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. It is often associated with activating mutations in KRAS leading to deregulation of major signaling pathways as the RAS-RAF-MAPK and PI3K-Akt. However, the therapeutic options for CRC patients harboring somatic KRAS mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Maria Sofia, Melo, Soraia, Velho, Sérgia, Carneiro, Patrícia, Carneiro, Fátima, Seruca, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356572/
https://www.ncbi.nlm.nih.gov/pubmed/27602501
http://dx.doi.org/10.18632/oncotarget.11843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356572/
https://www.ncbi.nlm.nih.gov/pubmed/27602501
http://dx.doi.org/10.18632/oncotarget.11843

Ejemplares similares